Changes to Veteran community reintegration research needed to address diverse needs of Veterans and their communities

Abstract: The authors issue a call to the field to address the expansive reintegration needs of Veterans and their communities. Developing inclusive Veteran community reintegration research is crucial to the Veterans Health Administration's becoming a more inclusive learning health care delivery system. Work conducted by the Enhancing Veteran Community Reintegration Research multi-stakeholder partnership and project team found critical gaps in Veteran community reintegration research. These gaps included a lack of inclusivity, a need for an intentional shift to Veteran-engaged research designs in diverse settings of care and community contexts, and an integration of knowledge translation efforts in areas of health care outside rehabilitation.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P